Search Results - "Vaxman, Iuliana"

Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing by Cohen, Yael C., Zada, Mor, Wang, Shuang-Yin, Bornstein, Chamutal, David, Eyal, Moshe, Adi, Li, Baoguo, Shlomi-Loubaton, Shir, Gatt, Moshe E., Gur, Chamutal, Lavi, Noa, Ganzel, Chezi, Luttwak, Efrat, Chubar, Evgeni, Rouvio, Ory, Vaxman, Iuliana, Pasvolsky, Oren, Ballan, Mouna, Tadmor, Tamar, Nemets, Anatoly, Jarchowcky-Dolberg, Osnat, Shvetz, Olga, Laiba, Meirav, Shpilberg, Ofer, Dally, Najib, Avivi, Irit, Weiner, Assaf, Amit, Ido

“…Multiple myeloma (MM) is a neoplastic plasma-cell disorder characterized by clonal proliferation of malignant plasma cells. Despite extensive research, disease…”
Get full text

Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis by Itzhaki Ben Zadok, Osnat, Vaturi, Mordehay, Vaxman, Iuliana, Iakobishvili, Zaza, Rhurman-Shahar, Noa, Kornowski, Ran, Hamdan, Ashraf

“…Aims To compare the baseline cardiovascular characteristics of immunoglobulin light-chain (AL) and amyloid transthyretin (ATTR) cardiac amyloidosis (CA) and to…”
Get full text

Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents by Vaxman, Iuliana, Visram, Alissa, Kumar, Shaji, Dispenzieri, Angela, Buadi, Francis, Dingli, David, Lacy, Martha, Muchtar, Eli, Kapoor, Prashant, Hogan, William, Hayman, Suzanne, Leung, Nelson, Gonsalves, Wilson, Kourelis, Taxiarchis, Warsame, Rahma, Berger, Tamar, Gertz, Morie A.

“…Autologous stem cell transplantation (ASCT) has been used for treating multiple myeloma (MM) for over three decades and is generally reserved for patients…”
Get full text

Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma—a retrospective cohort study by Kagan, Kim Ben Tikva, Guz, Dmitri, Buchrits, Shira, Gurion, Ronit, Vaxman, Iuliana, Priss, Miriam, Groshar, David, Catalano, Onofrio A., Sherban, Adi, Raanani, Pia, Gafter-Gvili, Anat, Bernstine, Hanna

“…Background The clinical value of FDG-PET/CT for staging and monitoring treatment response in patients with aggressive lymphoma is well established. Conversely,…”
Get full text

Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients by Visram, Alissa, Vaxman, Iuliana, S. Al Saleh, Abdullah, Parmar, Harsh, Dispenzieri, Angela, Kapoor, Prashant, Lacy, Martha Q., Gertz, Morie A., Buadi, Francis K., Hayman, Suzanne R., Dingli, David, Warsame, Rahma, Kourelis, Taxiarchis, Siddiqui, Mustaqeem, Gonsalves, Wilson, Muchtar, Eli, Lust, John A., Leung, Nelson, Kyle, Robert A., Murray, David, Rajkumar, S. Vincent, Kumar, Shaji

“…Unlike IgG monoclonal proteins (MCPs), IgA MCP quantification is unreliable due to beta-migration of IgA MCPs on serum protein electrophoresis (SPEP). The…”
Get full text

Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis by Vaxman, Iuliana, Sidiqi, M. Hasib, Al Saleh, Abdullah S., Kumar, Shaji, Muchtar, Eli, Dispenzieri, Angela, Buadi, Francis, Dingli, David, Lacy, Martha, Hayman, Suzanne, Leung, Nelson, Gonsalves, Wilson, Kourelis, Taxiarchis, Warsame, Rahma, Hogan, William, Gertz, Morie

“…The goal of therapy in AL amyloidosis is to inhibit further production of the amyloidogenic light chains, thereby allowing organ recovery and improving…”
Get full text

Hemophagocytic lymphohistiocytosis as a harbinger of aggressive lymphoma: a case series by Pasvolsky, Oren, Zoref-Lorenz, Adi, Abadi, Uri, Geiger, Karyn Revital, Hayman, Lucille, Vaxman, Iuliana, Raanani, Pia, Leader, Avi

“…Hemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory syndrome, which can manifest either secondary to a variety of underlying causes, or due to…”
Get full text

Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38‐Targeted Lipid Nanoparticles by Tarab‐Ravski, Dana, Hazan‐Halevy, Inbal, Goldsmith, Meir, Stotsky‐Oterin, Lior, Breier, Dor, Naidu, Gonna Somu, Aitha, Anjaiah, Diesendruck, Yael, Ng, Brandon D., Barsheshet, Hagit, Berger, Tamar, Vaxman, Iuliana, Raanani, Pia, Peer, Dan

“…Multiple myeloma (MM) is a cancer of differentiated plasma cells that occurs in the bone marrow (BM). Despite the recent advancements in drug development, most…”
Get full text

P966: SMOLDERING MULTIPLE MYELOMA (MM) PROGRESSING TO ACTIVE MM DURING FOLLOW‐UP: REDUCED BONE DISEASE AND IMPROVED PROGRESSION‐FREE AND OVERALL SURVIVAL COMPARED TO DE‐NOVO NEWLY DIAGNOSED MM by Fridberg, Gil, Shragai, Tamir, Melamed, Natan, Trestman, Svetlana, Vaxman, Iuliana, Avivi, Irit, Cohen, Yael

Get full text

Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantation by Al Saleh, Abdullah S., Parmar, Harsh V., Vaxman, Iuliana, Visram, Alissa, Hasib Sidiqi, M., Muchtar, Eli, Buadi, Francis K., Dispenzieri, Angela, Warsame, Rahma, Lacy, Martha Q., Dingli, David, Gonsalves, Wilson I., Wolf, Robert C., Kourelis, Taxiarchis V., Hogan, William J., Hayman, Suzanne R., Kapoor, Prashant, Kumar, Shaji K., Gertz, Morie A.

Get full text

P1355: DELIVERY OF THERAPEUTIC RNA TO THE BONE MARROW IN MULTIPLE MYELOMA USING CD38‐TARGETED LIPID NANOPARTICLES by Tarab‐Ravski, Dana, Vaxman, Iuliana, Berger, Tamar, Hazan‐Halevy, Inbal, Raanani, Pia, Peer, Dan

Get full text

P1274: IMPACT OF AUTOLOGOUS TRANSPLANT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH NOVEL TRIPLETS: A SYSTEMATIC REVIEW AND META‐ANALYSIS by Amitai, Irina, Gurion, Ronit, Raanani, Pia, Vaxman, Iuliana, Yeshurun, Moshe, Magen, Hila, Gafter‐Gvili, Anat, Shargian, Liat

Get full text

P942: MULTIPLE MYELOMA OLIGOSECRETORY RELAPSE‐ A CROSS SECTIONAL HISTORICAL COHORT STUDY by Vaxman, Iuliana, Zamir, Itai, Cohen, Inbar, Fridberg, Gil, Shragai, Tamir, Trestman, Svetlana, Ziv, Tomer, Luttwak, Efrat, Shmuel, Ronit, Melamed, Natan, Levi, Shai, Avivi, Irit, Raanani, Pia, Dispenzieri, Angela, Gertz, Morie, Cohen, Yael

Get full text

P914: VENETOCLAX IN RELAPSE/REFRACTORY AL AMYLOIDOSIS‐ A MULTICENTER INTERNATIONAL RETROSPECTIVE REAL‐WORLD STUDY by Lebel, Eyal, Kastritis, Efstathios, Palladini, Giovanni, Milani, Paolo, Theodorakakou, Foteini, Aumann, Shlomzion, Lavi, Noa, Shargian, Liat, Magen, Hila, Cohen, Yael, Gatt, Moshe, Vaxman, Iuliana

Get full text

The short and long‐term characteristics and outcomes of patients with grade 1 myocardial uptake on cardiac scintigraphy by Itzhaki Ben Zadok, Osnat, Ruhrman‐Sahar, Noa, Mats, Israel, Vaxman, Iuliana, Shiyovich, Arthur, Aviv, Yaron, Vaturi, Mordehai, Wiessman, Maya, Shochat, Tzippy, Kandinov, Irit, Kornowski, Ran, Hamdan, Ashraf

“…Aims This study aimed to characterize the final diagnosis and prognosis of patients with grade 1 myocardial scintigraphy uptake, which is an unequivocal result…”
Get full text

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients by Visram, Alissa, Al Saleh, Abdullah S., Parmar, Harsh, McDonald, Jennifer S., Lieske, John C., Vaxman, Iuliana, Muchtar, Eli, Hobbs, Miriam, Fonder, Amie, Hwa, Yi L., Buadi, Francis K., Dingli, David, Lacy, Martha Q., Dispenzieri, Angela, Kapoor, Prashant, Hayman, Suzanne R., Warsame, Rahma, Kourelis, Taxiarchis V., Siddiqui, Mustaqeem, Gonsalves, Wilson I., Lust, John A., Kyle, Robert A., Vincent Rajkumar, S., Gertz, Morie A., Kumar, Shaji K., Leung, Nelson

“…A 24-h urine protein collection (24hUP), the gold standard for measuring albuminuria in systemic AL amyloidosis, is cumbersome and inaccurate. We…”
Get full text

Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide by Gertz, Morie A., Lee, Hee Eun, Eaton, John, Vaxman, Iuliana

“…Herein we present a patient that underwent a liver transplant due to primary biliary cholangitis (PBC) and after 9 years developed multiple myeloma. Following…”
Get full text

Waldenstrom's macroglobulinemia in the era of immunotherapy by Vaxman, Iuliana, Gertz, Morie

“…Waldenstrom macroglobulinemia (WM) is a lymphoplasmacytic lymphoma that presents with symptomatic anemia, thrombocytopenia, constitutional symptoms,…”
Get full text

Non-transplant eligible multiple myeloma: deciphering optimal first line regimens by Vaxman, Iuliana, Gertz, Morie

Get full text

How I approach smoldering multiple myeloma by Vaxman, Iuliana, Gertz, Morie A.

“…The current standard of care in smoldering multiple myeloma (SMM) is close surveillance, outside of clinical trials. Efforts are being made to understand the…”
Get full text